Glioblastoma Treatment with 2,5-Dimethyl-Celecoxib (DMC) in Vitro
by Nathaniel Soriano (9783639028294)

Glioblastoma Treatment with 2,5-Dimethyl-Celecoxib (DMC) in Vitro

Nathaniel Soriano

Release Date: 01 May 2008
Format: Paperback
Pages: 48
Category: Molecular Biology
Publisher: VDM Verlag
ISBN: 9783639028294
ISBN-10: 3639028295

2,5-dimethyl-celecoxib (DMC) is a close structural analog of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib (Celebrex) that lacks COX-2 inhibitory function yet maintains all of celecoxibs anti-tumor properties. We set out to investigate the potential of combining current glioblastoma chemotherapies with DMC as a new approach to enhance glioblastoma cell killing. DMC was not only able to enhance tumor cell killing when combined with other drugs but also induced glioblastoma growth arrest and apoptosis in low glucose and hypoxic conditions which are normally associated with chemoresistance. Therefore, if DMC were used in combination it may potentially be able to reverse this chemoresistance and restore or even enhance these drugs inhibitory effects. In addition, we also discovered inconsistencies between the MTT assay and other in vitro cell growth and survival assays. Hence, the MTT assay should be used with caution, and its results should be supported by other available in vitro assays.

AUD $97.95

 This title is not held in stock & is ordered from suppliers, subject to availability.

Write a customer review of Glioblastoma Treatment with 2,5-Dimethyl-Celecoxib (DMC) in Vitro.

If you like this title please tell others:

tell others

post to your Facebook wall post on Twitter post on Digg recommend to Stumbleupon bookmark on Delicious RSS feed send to a friend

Australian BookShop
Australian Bookshop. Established 2003
Shopping Cart Customer Support

International Online Store
of Inspiration
we ship everywhere
Australia Post
Australia Wide